Source: Υπουργείο Υγείας (CY) Revision Year: 2016 Publisher: Remedica Ltd, Aharnon Str., Limassol Industrial Estate, 3056 Limassol, Cyprus
An adjunct to oral anti-coagulation for prophylaxis of thrombo-embolism associated with prosthetic heart valves.
300-600 mg daily in three or four doses.
Perazodin is not recommended for children.
Perazodin should usually be taken before meals.
Oral administration.
Due to the low number of observations, experience with dipyridamole overdose is limited. Symptoms such as a warm feeling, flushes, sweating, restlessness, feeling of weakness, dizziness and anginal complaints can be expected. A drop in blood pressure and tachycardia might be observed.
Symptomatic therapy is recommended. Administration of xanthine derivatives (e.g. aminophylline) may reverse the haemodynamic effects of dipyridamole overdose. Due to its wide distribution to tissues and its predominantly hepatic elimination, dipyridamole is not likely to be accessible to enhanced removal procedures.
5 years.
Store below 25°C. Protected from light and moisture.
Perazodin 25 mg coated tablets:
PVC/Aluminium blisters. Pack sizes of 100 and 1000 coated tablets.
PP containers with PE closure. Pack size of 1000 coated tablets
Perazodin 75 mg coated tablets:
PVC/Aluminium blisters. Pack sizes of 20, 30, 100 and 1000 coated tablets.
Perazodin 100 mg coated tablets:
PVC/Aluminium blisters. Pack sizes of 30, 100 and 1000 coated tablets.
No special requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
